Von willebrand factor is elevated in individuals infected with Sudan Virus and is associated with adverse clinical outcomes

Viral Immunology

Volumn 28, Issue 1, 2015, Pages 71-73

  McElroy, Anita K ^a,b   Erickson, Bobbie R ^a   Flietstra, Timothy D ^a   Rollin, Pierre E ^a   Towner, Jonathan S ^a   Nichol, Stuart T ^a   Spiropoulou, Christina F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; DISINTEGRIN; L SELECTIN; METALLOPROTEINASE; PADGEM PROTEIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; BIOLOGICAL MARKER;

ADVERSE OUTCOME; ARTICLE; BLEEDING DISORDER; DISEASE SEVERITY; ENDOTHELIUM; FATALITY; FILOVIRUS INFECTION; HEMATEMESIS; HUMAN; MELENA; MUCOSAL BLEEDING; RECTUM HEMORRHAGE; SUDAN VIRUS INFECTION; THROMBOCYTE ADHESION; THROMBOSIS; VON WILLEBRAND DISEASE; ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; BLOOD; CHILD; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; FEMALE; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; SURVIVAL; TREATMENT OUTCOME; YOUNG ADULT;

FILOVIRIDAE;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; BIOMARKERS; CHILD; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 84920847848     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0072     Document Type: Article

References (17)

1. Brill A, Fuchs TA, Chauhan AK, et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011;117:1400-1407.
2. Djamiatun K, Van Der Ven AJ, de Groot PG, et al. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. PLoS Negl Trop Dis 2012;6:e1628.
3. Ghasemzadeh M, and Hosseini E. Platelet-leukocyte crosstalk: linking proinflammatory responses to procoagulant state. Thromb Res 2013;131:191-197.
4. Habe K, Wada H, Ito-Habe N, et al. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases. Thromb Res 2012; 129:598-602.
5. Laine O, Makela S, Mustonen J, et al. Platelet ligands and ADAMTS13 during Puumala hantavirus infection and associated thrombocytopenia. Blood Coagul Fibrinolysis 2011;22:468-472.
6. Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009;145:24-33.
7. Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998;18: 1359-1362.
8. McElroy AK, Erickson BR, Flietstra TD, et al. Biomarker correlates of survival in pediatric patients with Ebola virus disease. Emerg Infect Dis 2014 [Epub ahead of print]; DOI: 10.3201/eid2010.140430.
9. McElroy AK, Erickson BR, Flietstra TD, et al. Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis 2014;210:558-566.
10. Page AV, and LilesWC. Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence 2013;4:507-516.
11. Ponthieux A, Herbeth B, Droesch S, et al. Biological determinants of serum ICAM-1, E-selectin, P-selectin and Lselectin levels in healthy subjects: the Stanislas study. Atherosclerosis 2004;172:299-308.
12. Raffler NA, Rivera-Nieves J, Ley K. L-selectin in inflammation, infection and immunity. Drug Discov Today 2005; 2:213-220.
13. Richards GA, Murphy S, Jobson R, et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med 2000;28:240-244.
14. Sanchez A, Geisbert T, and Feldmann H. Filoviridae: Marburg and Ebola Viruses. In: Knipe DM, Howley PM, eds. Fields Virology. Philadelphia: Lippincott Williams & Wilkins, 2006:1409-1439.
15. Sosothikul D, Seksarn P, Pongsewalak S, et al. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb Haemost 2007;97: 627-634.
16. Speth C, Löffler J, Krappmann S, et al. Platelets as immune cells in infectious diseases. Future Microbiol 2013;8:1431-1451.
17. Zheng XL. Structure-function and regulation of ADAMTS-13 protease. J Thromb Haemost 2013;11 Suppl 1:11-23.